https://www.selleckchem.com/pr....oducts/Nafamostat-me
05). Whereas the operation time and blood loss in group B were greater than those in group A ( 0.05), the VAS-neck, VAS-arm, NDI, and SF-36 scores were better in group B ( 0.05). The surgical complication rate between the two groups was not significantly different ( 0.05). Clinical efficacy of ACDF plus uncovertebrectomy for the treatment of patients with CSR may be better than that of ACDF alone, but at the expense of more operation time and blood loss. Clinical efficacy of ACDF plus uncovertebrectomy fo